SICKLE-Β0-THALASSEMIA (HBSΒ0)

Clinical trials for SICKLE-Β0-THALASSEMIA (HBSΒ0) explained in plain language.

Never miss a new study

Get alerted when new SICKLE-Β0-THALASSEMIA (HBSΒ0) trials appear

Sign up with your email to follow new studies for SICKLE-Β0-THALASSEMIA (HBSΒ0), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New approach to sickle cell treatment aims to protect young organs

Disease control Recruiting now

This study is testing a personalized way to determine the starting dose of hydroxyurea, a standard medication for sickle cell anemia, in young children. Instead of using only weight-based dosing, researchers will use blood tests to understand how each child's body processes the m…

Matched conditions: SICKLE-Β0-THALASSEMIA (HBSΒ0)

Phase: PHASE4 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

SICKLE-Β0-THALASSEMIA (HBSΒ0)

Get alerted when new SICKLE-Β0-THALASSEMIA (HBSΒ0) trials appear

New approach to sickle cell treatment aims to protect young organs